Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis

Sponsor
Uğur OVACIK (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04933110
Collaborator
Istanbul University-Cerrahpasa (Other)
90
2.5

Study Details

Study Description

Brief Summary

The upper extremity in people with Multiple Sclerosis (pwMS) has become a more popular research topic in recent years, with the increase in studies reporting widespread involvement. The aim of our study was to evaluate the upper extremity from multiple perspectives in early stage pwMS, to identify problems by comparing them with healthy individuals, and to examine the relationship of problems with activity and participation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    90 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis in the Very Early Stage.
    Anticipated Study Start Date :
    Jul 5, 2021
    Anticipated Primary Completion Date :
    Sep 6, 2021
    Anticipated Study Completion Date :
    Sep 20, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Multiple Sclerosis

    Individuals with early-stage multiple sclerosis

    Healthy Volunteers

    Healthy volunteers of similar age and sex as individuals with multiple sclerosis

    Outcome Measures

    Primary Outcome Measures

    1. Nine Hole Peg Test [baseline (on the predetermined assessment day)]

      To assess upper extremity function. Completing the test in a short time (seconds) indicates better upper extremity function.

    2. Minnesota Manual Dexterity Test [baseline (on the predetermined assessment day)]

      To assess upper extremity function. Completing the test in a short time (seconds) indicates better upper extremity function.

    3. ABILHAND [baseline (on the predetermined assessment day)]

      To assess for performance of activity. Score range 0-46 point, higher scores mean a better outcome.

    4. Motor Activity Log-28 [baseline (on the predetermined assessment day)]

      To assess for performance of activity. Score range 0-5 point, a high score indicates good upper extremity use frequency and quality of movement during activity.

    5. Community Integration Questionnaire [baseline (on the predetermined assessment day)]

      To assess participation. The total score ranges from 0-29, and the higher the score, the higher the individual's participation in society is considered.

    Secondary Outcome Measures

    1. Hand Held Dynamometer [baseline (on the predetermined assessment day)]

      To assess upper extremity muscle strength. Higher scores indicate better muscle strength.

    2. Hand Dynamometer [baseline (on the predetermined assessment day)]

      To assess grip strength. Higher scores indicate better muscle strength.

    3. Pinchmeter [baseline (on the predetermined assessment day)]

      To assess pinch strength. Higher scores indicate better muscle strength.

    4. Tuning fork [baseline (on the predetermined assessment day)]

      To assess deep sense. A higher score indicates better sensitivity.

    5. Aesthesiometer [baseline (on the predetermined assessment day)]

      To assess two-point discrimination. A higher score indicates worse sensitivity.

    6. Fatigue Severity Scale [baseline (on the predetermined assessment day)]

      To assess the severity of fatigue. Score range 1-7 point, a higher score indicates more severe fatigue.

    7. Symbol Digit Modalities Test [baseline (on the predetermined assessment day)]

      To assess cognitive level. A higher score indicates better cognitive level.

    8. Hospital Anxiety and Depression Scale [baseline (on the predetermined assessment day)]

      To assess anxiety and depression. The total score ranges from 0 to 21 for each of the two subscales. A higher score indicates more severe anxiety and depression.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • MS diagnosis according to McDonald criteria

    • Relapsing Remitting MS clinical course type

    • 18-65 age range

    • Being able to understand and read Turkish

    Exclusion Criteria:
    • Having an MS attack in the last 3 months

    • To have done regular exercise for the upper extremity in the 6 months before starting the study

    • Having different neurological, orthopedic or cardiac problems other than MS

    • Being addicted to alcohol or drugs

    • Getting a score below 24 on the Mini Mental Test Scale

    • Having a spasticity of 3 or more according to the Modified Ashworth Scale

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Uğur OVACIK
    • Istanbul University-Cerrahpasa

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Uğur OVACIK, Principal Investigator, PT, Msc, Istanbul Aydın University
    ClinicalTrials.gov Identifier:
    NCT04933110
    Other Study ID Numbers:
    • İAÜ2
    First Posted:
    Jun 21, 2021
    Last Update Posted:
    Jun 25, 2021
    Last Verified:
    Jun 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Uğur OVACIK, Principal Investigator, PT, Msc, Istanbul Aydın University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 25, 2021